首页> 外文期刊>Annals of the New York Academy of Sciences >Parasite Mitochondria as a Target of Chemotherapy: Inhibitory Effect of Licochalcone A on the Plasmodium falciparum Respiratory Chain
【24h】

Parasite Mitochondria as a Target of Chemotherapy: Inhibitory Effect of Licochalcone A on the Plasmodium falciparum Respiratory Chain

机译:寄生虫线粒体作为化学疗法的目标:利考查酮A对恶性疟原虫呼吸链的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Parasites have exploited unique energy metabolic pathways as adaptations to the natural host habitat. In fact, the respiratory systems of parasites typically show greater diversity in electron transfer pathways than do those of host animals. These unique aspects of parasite mitochondria and related enzymes may represent promising targets for chemotherapy. Natural products have been recognized as a source of the candidates of the specific inhibitors for such parasite respiratory chains. Chalcones was recently evaluated for its antimalarial activity in vitro and in vivo. However, its target is still unclear in malaria parasites. In this study, we investigated that licochalcone A inhibited the bc_1 complex (ubiquinol-cytochrome c reductase) as well as complex Ⅱ (suc-cinate ubiquinone reductase, SQR) of Plasmodium falciparum mitochondria. In particular, licochalcone A inhibits bc_1 complex activity at very low concentrations. Because the property of the P. falciparum bc_1 complex is different from that of the mammalian host, chalcones would be a promising candidate for a new antimalarial drug.
机译:寄生虫已利用独特的能量代谢途径来适应自然宿主栖息地。实际上,与宿主动物相比,寄生虫的呼吸系统通常在电子传递途径中表现出更大的多样性。寄生虫线粒体和相关酶的这些独特方面可能代表了有希望的化疗靶标。天然产物已被认为是这种寄生虫呼吸链的特定抑制剂候选物的来源。最近评估了Chalcones在体外和体内的抗疟活性。但是,其目标仍不清楚疟疾寄生虫。在这项研究中,我们调查了licochalcone A抑制恶性疟原虫线粒体的bc_1复合物(泛醇-细胞色素c还原酶)和复合物Ⅱ(蔗糖酸泛醌还原酶,SQR)。尤其是,甘草二烯A在非常低的浓度下抑制bc_1复合物的活性。由于恶性疟原虫bc_1复合物的特性与哺乳动物宿主的特性不同,查耳酮将成为新的抗疟药的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号